Kristine Peterson - 27 May 2026 Form 4 Insider Report for Immunocore Holdings plc (IMCR)

Reporting relationship: Director
Issuer ticker: IMCR
Reported as of: 27 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 May 2026, 19:55:13 UTC
Prior SEC filing: 13 Mar 2026
Next SEC filing: 22 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Lily Hepworth, Attorney-in-Fact

Key filing fact

Kristine Peterson filed Form 4 for Immunocore Holdings plc (IMCR) on 28 May 2026.

Key facts

This page summarizes Kristine Peterson's Form 4 filing for Immunocore Holdings plc (IMCR).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 May 2026, 19:55.

Change

Previous filing in this sequence was filed on 13 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001508596 Primary reporting owner

Peterson Kristine

Relationship: Director
Address: C/O IMMUNOCORE HOLDINGS PLC, 92 PARK DRIVE, MILTON PARK, ABINGDON, UNITED KINGDOM
Signature: /s/ Lily Hepworth, Attorney-in-Fact
Signature date: 28 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMCR transaction Derivative

Share Option (Right to Buy)

Award

Transaction value
Shares: +27,492
Change %
Price: $0.000000^*
Shares after: 27,492
Date: 27 May 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 27,492
Exercise price: $28.52
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option award shall vest at the earlier of (i) May 27, 2027 and (ii) the day immediately prior to the date of the Issuer's next annual general meeting, subject to the Reporting Person's continuous service through such vesting date.